Zocco, Maria Assunta
 Distribuzione geografica
Continente #
NA - Nord America 8.399
EU - Europa 7.272
AS - Asia 6.941
SA - Sud America 1.209
AF - Africa 203
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 23
Totale 24.105
Nazione #
US - Stati Uniti d'America 8.103
SG - Singapore 3.047
DE - Germania 2.623
CN - Cina 1.619
IT - Italia 1.124
SE - Svezia 1.114
BR - Brasile 954
VN - Vietnam 635
FR - Francia 536
UA - Ucraina 382
GB - Regno Unito 367
IE - Irlanda 257
IN - India 257
FI - Finlandia 233
JP - Giappone 216
BD - Bangladesh 208
ID - Indonesia 182
CA - Canada 161
RU - Federazione Russa 142
HK - Hong Kong 134
TR - Turchia 130
PL - Polonia 102
AR - Argentina 96
IQ - Iraq 74
NL - Olanda 72
MX - Messico 69
KR - Corea 67
BE - Belgio 57
SA - Arabia Saudita 55
AU - Australia 53
ZA - Sudafrica 51
AT - Austria 39
PH - Filippine 39
IR - Iran 38
EC - Ecuador 34
PK - Pakistan 32
VE - Venezuela 31
CH - Svizzera 30
LT - Lituania 29
ES - Italia 28
AE - Emirati Arabi Uniti 26
CZ - Repubblica Ceca 25
EG - Egitto 23
IL - Israele 22
RO - Romania 22
CL - Cile 21
MA - Marocco 21
CO - Colombia 20
KE - Kenya 20
PY - Paraguay 20
CI - Costa d'Avorio 18
JO - Giordania 18
TN - Tunisia 18
UZ - Uzbekistan 18
PE - Perù 17
EU - Europa 16
TW - Taiwan 16
MY - Malesia 15
JM - Giamaica 13
UY - Uruguay 13
GR - Grecia 11
NP - Nepal 11
PT - Portogallo 11
TT - Trinidad e Tobago 11
AZ - Azerbaigian 10
ET - Etiopia 8
KZ - Kazakistan 8
PA - Panama 8
TH - Thailandia 8
AL - Albania 7
CR - Costa Rica 7
DZ - Algeria 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
AO - Angola 6
BH - Bahrain 6
HN - Honduras 6
LB - Libano 6
SD - Sudan 6
SN - Senegal 6
CY - Cipro 5
DO - Repubblica Dominicana 5
EE - Estonia 5
GE - Georgia 5
HR - Croazia 5
MD - Moldavia 5
NG - Nigeria 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BY - Bielorussia 4
LK - Sri Lanka 4
LV - Lettonia 4
ML - Mali 4
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
A1 - Anonimo 3
BO - Bolivia 3
Totale 24.046
Città #
Singapore 1.759
Ashburn 917
Chandler 910
San Jose 840
New York 322
Beijing 315
Dallas 286
Rome 258
Dublin 254
Hefei 227
Los Angeles 225
Ho Chi Minh City 209
Tokyo 201
Jacksonville 192
San Mateo 190
Munich 180
Ann Arbor 167
Jakarta 162
Nürnberg 157
Lauterbourg 154
Milan 152
The Dalles 151
Hanoi 150
Chicago 136
Nanjing 132
Frankfurt am Main 125
Cattolica 120
Marseille 119
Hong Kong 118
Wilmington 109
Boston 101
Council Bluffs 99
Helsinki 92
Boardman 91
Buffalo 89
São Paulo 89
Izmir 80
Woodbridge 79
Moscow 75
Princeton 73
Santa Clara 70
Seattle 70
Dearborn 68
Kent 67
Bremen 64
Seoul 58
Warsaw 55
Brussels 51
Houston 51
Turku 50
Nanchang 45
Orem 45
St Louis 44
Tukwila 44
London 43
Brooklyn 42
Düsseldorf 41
Hangzhou 39
Redwood City 39
Toronto 39
Fairfield 35
Nuremberg 35
Tianjin 35
North Bergen 34
Zhengzhou 34
Da Nang 33
Denver 30
Haiphong 30
Chennai 29
Rio de Janeiro 29
Atlanta 28
Hebei 28
Lawrence 28
Kraków 27
Montreal 27
Augusta 26
Lancaster 26
Pune 26
Shanghai 26
Stockholm 26
Norwalk 25
Paris 25
Amsterdam 24
Guangzhou 24
Hyderabad 24
Johannesburg 24
University Park 24
Baghdad 23
Leawood 23
Manchester 23
Lappeenranta 22
Poplar 22
Changsha 21
Mountain View 21
Phoenix 20
Portsmouth 20
Shenyang 20
Fremont 19
Mexico City 19
Abidjan 18
Totale 12.163
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 527
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 345
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 333
-The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure 265
13C-methionine breath tests for mitochondrial liver function assessment. 262
The role of small intestinal bacterial overgrowth in Parkinson's disease 250
13C-breath tests in the study of microsomal liver function 244
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 238
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 237
-Hepatic steatosis and vascular disease 236
-Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure 235
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 231
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 230
-High prevalence of celiac disease in patients with lactose intolerance 230
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 226
134C-breath tests in the study of mitochondrial liver function 218
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 215
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 215
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 213
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 212
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 207
Malnutrition in COVID-19 survivors: prevalence and risk factors 202
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 202
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 202
13C-breath tests in the study of microsomial liver function 202
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 200
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 198
COVID-19 atypical Parsonage-Turner syndrome: a case report 195
13C-methionine breath tests for mitochondrial liver function assessment 193
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 191
Liver transplantation in patients with alcoholic liver disease: A retrospective study 191
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 190
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 190
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 185
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 182
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. 180
-Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis 179
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 179
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease 177
. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. 177
Residual respiratory impairment after COVID-19 pneumonia 177
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 176
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 176
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 175
Treatment of H. pylori infection: a review. 172
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test 171
-Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis 170
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 170
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 170
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. 167
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 167
Transdifferentiation of stem cells in pancreatic cells: state of the art 166
13C-breath tests in the study of mitochondrial liver function 165
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 165
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet. 163
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. 162
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 161
-Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? 161
Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies 160
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 159
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 159
Diagnosis of bowel diseases: the role of imaging and ultrasonography 158
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 156
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota 156
Levofloxacin based regimens for the eradication of Helicobacter pylori 154
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 151
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 150
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 149
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 148
-From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? 148
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis 147
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 144
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 144
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 142
Different Antibiotic No Culture Eradicating (DANCE) strategy: An easy way to manage H. pylori eradication 142
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 139
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 139
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 136
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon 133
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication 133
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 133
Madelung's disease and acute alcoholic hepatitis: case report and review of literature 132
Anticoagulants in cirrhotic patients: controversies and certainties in PVT management 131
The role of elastography in non-Alcoholic fatty liver disease 130
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 129
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 128
Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic Use 128
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 128
A) Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation 127
Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? 126
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons 125
Shear-wave elastography to predict hepatocellular carcinoma after hepatitis C virus eradication: A systematic review and meta-analysis 124
Endoscopic Contrast-Enhanced Ultrasound and Fine-Needle Aspiration or Biopsy for the Diagnosis of Pancreatic Solid Lesions: A Systematic Review and Meta-Analysis 124
Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases 124
Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives 124
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 123
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective 123
Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease 122
Probiotics and small bowel mucosa: Molecular aspects of their interactions 121
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 120
Totale 17.787
Categoria #
all - tutte 95.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/20221.176 86 97 36 95 94 35 25 190 34 64 185 235
2022/20233.146 349 349 254 523 270 398 187 215 309 122 121 49
2023/20241.533 79 356 60 44 66 262 89 48 30 118 168 213
2024/20253.689 68 80 276 137 303 109 168 205 509 389 830 615
2025/20269.727 1.249 293 774 1.040 1.534 464 1.627 477 769 575 464 461
Totale 24.354